Scarica l'app Stockscreener
355.53
1.17%
-4.21
Dopo l'orario di chiusura:
355.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$359.74
Aprire:
$359.82
Volume 24 ore:
780.94K
Relative Volume:
0.76
Capitalizzazione di mercato:
$34.91B
Reddito:
$3.77B
Utile/perdita netta:
$449.25M
Rapporto P/E:
45.26
EPS:
7.8556
Flusso di cassa netto:
$240.68M
1 W Prestazione:
-2.69%
1M Prestazione:
+0.94%
6M Prestazione:
-7.73%
1 anno Prestazione:
+1.70%
Intervallo 1D:
$354.78
$365.00
Intervallo di 1 settimana:
$354.42
$377.51
Portata 52W:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Nome
Waters Corp
Settore
Industria
Telefono
(508) 478-2000
Indirizzo
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
355.53 | 34.91B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
469.34 | 174.42B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.10 | 127.47B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.88 | 44.24B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
129.84 | 36.67B | 7.23B | 1.41B | 1.09B | 4.979 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2026-02-10 | Ripresa | Barclays | Overweight |
| 2026-02-10 | Ripresa | Citigroup | Buy |
| 2026-02-10 | Ripresa | Evercore ISI | In-line |
| 2026-01-06 | Iniziato | Guggenheim | Buy |
| 2026-01-05 | Iniziato | William Blair | Outperform |
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-01 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2023-11-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-05-18 | Iniziato | Barclays | Overweight |
| 2022-05-17 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Aggiornamento | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Aggiornamento | Citigroup | Sell → Neutral |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Downgrade | Needham | Hold → Underperform |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Sell |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-09 | Downgrade | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-01-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Iniziato | Needham | Hold |
| 2018-12-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Downgrade | Goldman | Neutral → Sell |
| 2018-10-11 | Aggiornamento | Cleveland Research | Sell → Neutral |
Mostra tutto
Waters Corp Borsa (WAT) Ultime notizie
Waters Corp. stock outperforms competitors on strong trading day - MSN
Waters Launches New Tools As Investors Weigh Biologics And Battery Upside - Yahoo Finance
Waters Corp. stock outperforms competitors despite losses on the day - MarketWatch
Waters Corporation ACQUITY Premier System: UHPLC workhorse for demanding labs - AD HOC NEWS
Waters targets earlier thermal runaway detection with whole-cell coin cell differential scanning calorimeter - R&D World
Piper Sandler initiates Waters stock coverage with neutral rating - Investing.com
Waters Corporation Stock (US9418481035): New Coin Cell DSC Launch Puts Materials Analysis In Focus - AD HOC NEWS
Waters Company Profile & Introduction - Moomoo
Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Waters launches coin cell calorimeter for battery testing - Investing.com
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis – Company AnnouncementFT.com - Financial Times
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis - Finviz
New Waters columns speed testing for GLP‑1, insulin and LNP drug substances - Stock Titan
2026 Power 100: Udit Batra - Worcester Business Journal
What Just Happened with BD and Waters - Kavout
Waters Corporation $WAT Shares Sold by Bank of New York Mellon Corp - MarketBeat
ETFs Investing in Waters Corporation Stocks - TradingView
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Waters Corporation stock (US9418481035): valuation metrics in focus after recent product news - AD HOC NEWS
Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com
T. Rowe Price Capital Appreciation Fund's Waters Corp(WAT) Holding History - GuruFocus
Waters (WAT) Gains FDA Clearance for Automated Blood Culture Sys - GuruFocus
Waters Corp at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics - Sharecast.com
FDA-cleared blood culture system flags sepsis infections 3 hours faster - Stock Titan
Kevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.com
10,716 Shares in Waters Corporation $WAT Bought by BW Gestao de Investimentos Ltda. - MarketBeat
Waters Corp Coverage Assumed by Wolfe Research at Outperform - Moomoo
Wolfe Research initiates Waters stock with Outperform rating By Investing.com - Investing.com India
Waters Corp stock (US94106L1098): new mass spectrometry launch highlights innovation ahead of next e - AD HOC NEWS
Wolfe Research initiates Waters stock with Outperform rating - Investing.com UK
Waters Corporation stock (US9418481035): shares steady after May analyst updates and Q1 earnings - AD HOC NEWS
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research - Sharecast.com
New Waters Cyclic IMS P20 maps disease signals in tissue - Stock Titan
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics - Yahoo Finance
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - MSN
Waters Corporation stock (US9418481035): shares hover near recent highs ahead of technical levels - AD HOC NEWS
Waters Corp. Hits Day High with Strong 7.16% Intraday Surge - Markets Mojo
Top Waters (WAT) Competitors 2026 - MarketBeat
Waters Corp (WAT) Stock Up 7.2% and Still Undervalued -- GF Score: 91/100 - GuruFocus
Waters Corp Stock (WAT) Closed Up by 7.23% on May 28: What Investors Need To Know - TradingKey
Waters Jumps 5.3% Amid Sector-Wide Rally - AlphaStreet
Waters Corporation stock (US9418481035): shares edge higher ahead of Jefferies healthcare conference - AD HOC NEWS
Waters Corporation stock (US9418481035): Stable demand after recent earnings update - AD HOC NEWS
Waters Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Are Wall Street analysts bullish on Waters Corporation stock? - MSN
Board Appointments Strengthen New Waters CompanyScoop - Scoop - New Zealand News
Board appointments strengthen new waters company - Hamilton City Council
Waters Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Are Wall Street Analysts Bullish on Waters Corporation Stock? - Yahoo Finance
Waters Corp Azioni (WAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.22%
3.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):